Cerebral abscess in a multiple sclerosis patient during treatment with natalizumab

被引：0
|
作者：
B. Durmus
J. Van Goethem
A. Vercruyssen
G. De la Meilleure
C. Jadoul
B. Willekens
机构：
[1] AZ Nikolaas,Department of Neurology
[2] AZ Nikolaas,Department of Radiology
[3] Moerlandstraat 1,Department of Neurology
[4] 9100,Laboratory of Experimental Hematology
[5] Department of Radiology,undefined
[6] Antwerp University Hospital,undefined
[7] Antwerp University Hospital,undefined
[8] University of Antwerp,undefined
来源：
Acta Neurologica Belgica | 2020年 / 120卷
关键词：
Natalizumab; Abscess; Bacterial infection; Multiple sclerosis; Immune system;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：215 / 217
页数：2
相关论文
共 50 条
  • [41] Cryptococcal meningitis in a multiple sclerosis patient taking natalizumab
    Valenzuela, Reuben Mari
    Pula, John H.
    Garwacki, Dennis
    Cotter, John
    Kattah, Jorge C.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 340 (1-2) : 109 - 111
  • [42] Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring
    Raed A Alroughani
    Hany M Aref
    Saeed A Bohlega
    Maurice P Dahdaleh
    Imed Feki
    Mohammed A Al Jumah
    Muhammad Z Al-Kawi
    Salam F Koussa
    Mohamad A Sahraian
    Isa A Alsharoqi
    Bassem I Yamout
    BMC Neurology, 14
  • [43] Varicella-zoster meningovasculitis in a multiple sclerosis patient treated with natalizumab
    Mulero, Patricia
    Auger, Cristina
    Parolin, Laura
    Fonseca, Elena
    Requena, Manuel
    Rio, Jordi
    Tintore, Mar
    Rovira, Alex
    Montalban, Xavier
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (03) : 358 - 360
  • [44] Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab
    De-Hyung Lee
    Anne Waschbisch
    Alexandra B Lämmer
    Arnd Doerfler
    Stefan Schwab
    Ralf A Linker
    Journal of Neuroinflammation, 10
  • [45] Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring
    Alroughani, Raed A.
    Aref, Hany M.
    Bohlega, Saeed A.
    Dahdaleh, Maurice P.
    Feki, Imed
    Al Jumah, Mohammed A.
    Al-Kawi, Muhammad Z.
    Koussa, Salam F.
    Sahraian, Mohamad A.
    Alsharoqi, Isa A.
    Yamout, Bassem I.
    BMC NEUROLOGY, 2014, 14
  • [46] Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis
    Petersen, Eva Rosa
    Sondergaard, Helle Bach
    Laursen, Julie Hejgaard
    Olsson, Anna Gabriella
    Boernsen, Lars
    Sorensen, Per Soelberg
    Sellebjerg, Finn
    Oturai, Annette Bang
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (09) : 1298 - 1305
  • [47] Natalizumab treatment of multiple sclerosis in Spain: results of an extensive observational study
    O. Fernández
    C. Oreja-Guevara
    R. Arroyo
    G. Izquierdo
    J. L. Pérez
    X. Montalban
    Journal of Neurology, 2012, 259 : 1814 - 1823
  • [48] Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal study
    Judith J Stephenson
    David M Kern
    Sonalee S Agarwal
    Ruth Zeidman
    Krithika Rajagopalan
    Siddhesh A Kamat
    John Foley
    Health and Quality of Life Outcomes, 10
  • [49] Neuron-binding antibody responses are associated with Black ethnicity in multiple sclerosis during natalizumab treatment
    Telesford, Kiel M.
    Smith, Chad
    Mettlen, Marcel
    Davis, Melissa B.
    Cowell, Lindsay
    Kittles, Rick
    Vartanian, Timothy
    Monson, Nancy
    BRAIN COMMUNICATIONS, 2023, 5 (04)
  • [50] CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patients
    Carotenuto, Antonio
    Scalia, Giulia
    Ausiello, Francesco
    Moccia, Marcello
    Russo, Cinzia Valeria
    Sacca, Francesco
    De Rosa, Anna
    Criscuolo, Chiara
    Del Vecchio, Luigi
    Morra, Vincenzo Brescia
    Lanzillo, Roberta
    JOURNAL OF NEUROIMMUNOLOGY, 2017, 309 : 47 - 50
12345